MID,citation,unknown0,title,authors,journal,year,url
153,Hayden FG. Pandemic influenza: is an antiviral response realistic? Pediatr Infect Dis J 2004;23:Suppl:S262-S269.,10.1097/01.inf.0000144680.39895.ce,Pandemic Influenza: Is an Antiviral Response Realistic?,"[[u'Frederick', u'G.', u'Hayden']]",Pediatric Infectious Disease Journal,2004,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00006454-200411001-00012']
153,"Matrosovich MN, Matrosovich TY, Gray T, Roberts NA, Klenk HD. Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium. J Virol 2004;78:12665-7.",10.1128/JVI.78.22.12665-12667.2004,Neuraminidase Is Important for the Initiation of Influenza Virus Infection in Human Airway Epithelium,"[[u'Mikhail', u'N.', u'Matrosovich'], [u'Tatyana', u'Y.', u'Matrosovich'], [u'Thomas', u'', u'Gray'], [u'Noel', u'A.', u'Roberts'], [u'Hans-Dieter', u'', u'Klenk']]",Journal of Virology,2004,"[u'http://jvi.asm.org/cgi/reprint/78/22/12665.pdf', u'http://jvi.asm.org/cgi/doi/10.1128/JVI.78.22.12665-12667.2004']"
153,"Meindl P, Bodo G, Palese P, Schulman J, Tuppy H. Inhibition of neuraminidase activity by derivatives of 2-deoxy-2,3-dehydroN-acetylneuraminic acid. Virology 1974;58: 457-63.",10.1016/0042-6822(74)90080-4,"Inhibition of neuraminidase activity by derivatives of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid","[[u'P.', u'', u'Meindl'], [u'G.', u'', u'Bodo'], [u'P.', u'', u'Palese'], [u'J.', u'', u'Schulman'], [u'H.', u'', u'Tuppy']]",Virology,1974,[u'http://linkinghub.elsevier.com/retrieve/pii/0042682274900804']
153,"Palese P, Compans RW. Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action. J Gen Virol 1976;33:159-63.",10.1099/0022-1317-33-1-159,"Inhibition of Influenza Virus Replication in Tissue Culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): Mechanism of Action","[[u'P.', u'', u'Palese'], [u'R.', u'W.', u'Compans']]",Journal of General Virology,1976,[u'http://vir.sgmjournals.org/cgi/doi/10.1099/0022-1317-33-1-159']
153,"Palese P, Schulman JL, Bodo G, Meindl P. Inhibition of influenza and parainfluenza virus replication in tissue culture by 2-deoxy2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA). Virology 1974;59:490-8.",10.1016/0042-6822(74)90458-9,"Inhibition of influenza and parainfluenza virus replication in tissue culture by 2-deoxy-2,3-dehydro--trifluoroacetylneuraminic acid (FANA)","[[u'P', u'', u'PALESE'], [u'J', u'', u'SCHULMAN'], [u'G', u'', u'BODO'], [u'P', u'', u'MEINDL']]",Virology,1974,[u'http://linkinghub.elsevier.com/retrieve/pii/0042682274904589']
153,"Colman PM, Varghese JN, Laver WG. Structure of the catalytic and antigenic sites in influenza virus neuraminidase. Nature 1983;303:41-4.",10.1038/303041a0,Structure of the catalytic and antigenic sites in influenza virus neuraminidase,"[[u'P.', u'M.', u'Colman'], [u'J.', u'N.', u'Varghese'], [u'W.', u'G.', u'Laver']]",Nature,1983,[u'http://www.nature.com/doifinder/10.1038/303041a0']
153,"Varghese JN, McKimm-Breschkin JL, Caldwell JB, Kortt AA, Colman PM. The structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptor. Proteins 1992;14:327-32.",10.1002/prot.340140302,"The structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptor","[[u'Joseph', u'N.', u'Varghese'], [u'Jennifer', u'L.', u'McKimm-Breschkin'], [u'James', u'B.', u'Caldwell'], [u'Alexander', u'A.', u'Kortt'], [u'Peter', u'M.', u'Colman']]",Proteins-structure Function and Bioinformatics,1992,[u'http://doi.wiley.com/10.1002/prot.340140302']
153,"von Itzstein M, Wu W-Y, Kok GB, et al. Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature 1993;363:418-23.",10.1038/363418a0,Rational design of potent sialidase-based inhibitors of influenza virus replication,"[[u'Mark', u'von', u'Itzstein'], [u'Wen-Yang', u'', u'Wu'], [u'Gaik', u'B.', u'Kok'], [u'Michael', u'S.', u'Pegg'], [u'Jeffrey', u'C.', u'Dyason'], [u'Betty', u'', u'Jin'], [u'Tho', u'Van', u'Phan'], [u'Mark', u'L.', u'Smythe'], [u'Hume', u'F.', u'White'], [u'Stuart', u'W.', u'Oliver'], [u'Peter', u'M.', u'Colman'], [u'Joseph', u'N.', u'Varghese'], [u'D.', u'Michael', u'Ryan'], [u'Jacqueline', u'M.', u'Woods'], [u'Richard', u'C.', u'Bethell'], [u'Vanessa', u'J.', u'Hotham'], [u'Janet', u'M.', u'Cameron'], [u'Charles', u'R.', u'Penn']]",Nature,1993,[u'http://www.nature.com/doifinder/10.1038/363418a0']
153,"Varghese JN, Epa VC, Colman PM. Threedimensional structure of the complex of 4-guanidino-Neu5Ac2en and influenza virus neuraminidase. Protein Sci 1995;4:1081-7.",10.1002/pro.5560040606,Three-dimensional structure of the complex of 4-guanidino-Neu5Ac2en and influenza virus neuraminidase,"[[u'Joseph', u'N.', u'Varghese'], [u'V.', u'Chandana', u'Epa'], [u'Peter', u'M.', u'Colman']]",Protein Science,2008,[u'http://doi.wiley.com/10.1002/pro.5560040606']
153,"Kim CU, Lew W, Williams MA, et al. Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity. J Am Chem Soc 1997;119:681-90.",10.1021/ja963036t,"Influenza Neuraminidase Inhibitors Possessing a Novel Hydrophobic Interaction in the Enzyme Active Site:  Design, Synthesis, and Structural Analysis of Carbocyclic Sialic Acid Analogues with Potent Anti-Influenza Activity","[[u'Choung', u'U.', u'Kim'], [u'Willard', u'', u'Lew'], [u'Matthew', u'A.', u'Williams'], [u'Hongtao', u'', u'Liu'], [u'Lijun', u'', u'Zhang'], [u'S.', u'', u'Swaminathan'], [u'Norbert', u'', u'Bischofberger'], [u'Ming', u'S.', u'Chen'], [u'Dirk', u'B.', u'Mendel'], [u'Chun', u'Y.', u'Tai'], [u'W.', u'Graeme', u'Laver'], [u'Raymond', u'C.', u'Stevens']]",Journal of The American Chemical Society,1997,[u'http://pubs.acs.org/doi/abs/10.1021/ja963036t']
153,"Cass LM, Brown J, Pickford M, et al. Pharmacoscintigraphic evaluation of lung deposition of inhaled zanamivir in healthy volunteers. Clin Pharmacokinet 1999;36: Suppl 1:21-31.",10.2165/00003088-199936001-00003,Pharmacoscintigraphic Evaluation of Lung Deposition of Inhaled Zanamivir in Healthy Volunteers,"[[u'Lindsey', u'M. R.', u'Cass'], [u'Joanne', u'', u'Brown'], [u'Matthew', u'', u'Pickford'], [u'Susan', u'', u'Fayinka'], [u'Stephen', u'P.', u'Newman'], [u'Carl', u'J.', u'Johansson'], [u'Alan', u'', u'Bye']]",Clinical Pharmacokinetics,1999,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00003088-199936001-00003']
153,"Hayden FG, Osterhaus AD, Treanor JJ, et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. N Engl J Med 1997;337:874-80.",10.1056/NEJM199709253371302,Efficacy and Safety of the Neuraminidase Inhibitor Zanamivir in the Treatment of Influenzavirus Infections,"[[u'Frederick', u'G.', u'Hayden'], [u'Albert', u'D. M. E.', u'Osterhaus'], [u'John', u'J.', u'Treanor'], [u'Douglas', u'M.', u'Fleming'], [u'Fred', u'Y.', u'Aoki'], [u'Karl', u'G.', u'Nicholson'], [u'Arthur', u'M.', u'Bohnen'], [u'Hilary', u'M.', u'Hirst'], [u'Oliver', u'', u'Keene'], [u'Kevin', u'', u'Wightman']]",New England Journal of Medicine,1997,[u'http://www.nejm.org/doi/abs/10.1056/NEJM199709253371302']
153,"Cooper NJ, Sutton AJ, Abrams KR, Wailoo A, Turner D, Nicholson KG. Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials. BMJ 2003;326:",10.1136/bmj.326.7401.1235,Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials,"[[u'Nicola', u'J', u'Cooper'], [u'Alexander', u'J', u'Sutton'], [u'Keith', u'R', u'Abrams'], [u'Allan', u'', u'Wailoo'], [u'David', u'A', u'Turner'], [u'Karl', u'G', u'Nicholson']]",British Medical Journal,2003,"[u'http://www.bmj.com/cgi/reprint/326/7401/1235.pdf', u'http://www.bmj.com/cgi/doi/10.1136/bmj.326.7401.1235']"
153,"Makela MJ, Pauksens K, Rostila T, et al. Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza: a randomized, double-blind, placebo-controlled European study. J Infect 2000;40:42-8. ",10.1053/jinf.1999.0602,"Clinical Efficacy and Safety of the Orally Inhaled Neuraminidase Inhibitor Zanamivir in the Treatment of Influenza: a Randomized, Double-blind, Placebo-controlled European Study","[[u'M.', u'J.', u'M\xe4kel\xe4'], [u'K.', u'', u'Pauksens'], [u'T.', u'', u'Rostila'], [u'D.', u'M.', u'Fleming'], [u'C.', u'Y.', u'Man'], [u'O.', u'N.', u'Keene'], [u'A.', u'', u'Webster']]",Journal of Infection,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0163445399906023', u'http://linkinghub.elsevier.com/retrieve/pii/S0163445399906023', u'http://download.thelancet.com/flatcontentassets/h1n1-flu/treatment/treatment-15.pdf']"
153,"Treanor JJ, Hayden FG, Vrooman PS, et al. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. JAMA 2000;283:1016-24.",10.1001/jama.283.8.1016,Efficacy and Safety of the Oral Neuraminidase Inhibitor Oseltamivir in Treating Acute Influenza: A Randomized Controlled Trial,"[[u'J.', u'J.', u'Treanor']]",Jama-journal of The American Medical Association,2000,[u'http://jama.ama-assn.org/cgi/doi/10.1001/jama.283.8.1016']
153,"Nicholson KG, Aoki FY, Osterhaus AD, et al. Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Lancet 2000;355:1845-50. [Erratum, Lancet 2000;356:1856.]",10.1016/S0140-6736(00)02288-1,Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial,"[[u'KG', u'', u'Nicholson'], [u'FY', u'', u'Aoki'], [u'ADME', u'', u'Osterhaus'], [u'S', u'', u'Trottier'], [u'O', u'', u'Carewicz'], [u'CH', u'', u'Mercier'], [u'A', u'', u'Rode'], [u'N', u'', u'Kinnersley'], [u'P', u'', u'Ward']]",Lancet,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0140673600022881', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673600022881']"
153,"Murphy KR, Eivindson A, Pauksens K, et al. Efficacy and safety of inhaled zanamivir for the treatment of influenza in patients with asthma or chronic obstructive pulmonary disease: a double-blind, randomised, placebo-controlled, multicentre study. Clin Drug Investig 2000;20:337-49.",10.2165/00044011-200020050-00005,"Efficacy and Safety of Inhaled Zanamivir for the Treatment of Influenza in Patients with Asthma or Chronic Obstructive Pulmonary Disease: A Double-Blind, Randomised, Placebo-Controlled, Multicentre Study","[[u'Kevin', u'R.', u'Murphy'], [u'Arne', u'', u'Eivindson'], [u'Karlis', u'', u'Pauksens'], [u'William', u'J.', u'Stein'], [u'Guy', u'', u'Tellier'], [u'Richard', u'', u'Watts'], [u'Stephen', u'J.', u'Sharp'], [u'Elke', u'', u'Loeschel']]",Clinical Drug Investigation,2000,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00044011-200020050-00005']
153,"Hedrick JA, Barzilai A, Behre U, et al. Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trial. Pediatr Infect Dis J 2000;19: 410-7.",10.1097/00006454-200005000-00005,Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trial,"[[u'JAMES', u'A.', u'HEDRICK'], [u'ASHER', u'', u'BARZILAI'], [u'ULRICH', u'', u'BEHRE'], [u'FREDERICK', u'W.', u'HENDERSON'], [u'JANET', u'', u'HAMMOND'], [u'LUCY', u'', u'REILLY'], [u'OLIVER', u'', u'KEENE']]",Pediatric Infectious Disease Journal,2000,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00006454-200005000-00005']
153,"Whitley RJ, Hayden FG, Reisinger KS, et al. Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J 2001;20: 127-33. [Erratum, Pediatr Infect Dis J 2001; 20:421.]",10.1097/00006454-200102000-00002,Oral oseltamivir treatment of influenza in children,"[[u'RICHARD', u'J.', u'WHITLEY'], [u'FREDERICK', u'G.', u'HAYDEN'], [u'KEITH', u'S.', u'REISINGER'], [u'NANCY', u'', u'YOUNG'], [u'REGINA', u'', u'DUTKOWSKI'], [u'DAVID', u'', u'IPE'], [u'ROGER', u'G.', u'MILLS'], [u'PENELOPE', u'', u'WARD']]",Pediatric Infectious Disease Journal,2001,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00006454-200102000-00002']
153,"Aoki FY, Macleod MD, Paggiaro P, et al. Early administration of oral oseltamivir increases the benefits of influenza treatment. J Antimicrob Chemother 2003;51:123-9.",10.1093/jac/dkg007,Early administration of oral oseltamivir increases the benefits of influenza treatment,"[[u'F.', u'Y.', u'Aoki']]",Journal of Antimicrobial Chemotherapy,2003,[u'http://www.jac.oupjournals.org/cgi/doi/10.1093/jac/dkg007']
153,"Kaiser L, Wat C, Mills T, Mahoney P, Ward P, Hayden F. Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations. Arch Intern Med 2003;163:1667-72.",,Impact of Oseltamivir Treatment on Influenza-Related Lower Respiratory Tract Complications and Hospitalizations,"[[u'Laurent', u'', u'Kaiser'], [u'Cynthia', u'', u'Wat'], [u'Tracy', u'', u'Mills'], [u'Paul', u'', u'Mahoney'], [u'Penelope', u'', u'Ward'], [u'Frederick', u'', u'Hayden']]",,2003,[u'http://archinte.ama-assn.org/cgi/reprint/163/14/1667.pdf']
153,"Kawai N, Ikematsu H, Iwaki N, et al. Factors influencing the effectiveness of oseltamivir and amantadine for the treatment of influenza: a multicenter study from Japan of the 2002-2003 influenza season. Clin Infect Dis 2005;40:1309-16.",10.1086/429241,Factors Influencing the Effectiveness of Oseltamivir and Amantadine for the Treatment of Influenza: A Multicenter Study from Japan of the 2002–2003 Influenza Season,"[[u'Naoki', u'', u'Kawai'], [u'Hideyuki', u'', u'Ikematsu'], [u'Norio', u'', u'Iwaki'], [u'Ietaka', u'', u'Satoh'], [u'Takashi', u'', u'Kawashima'], [u'Tetsunari', u'', u'Maeda'], [u'Kiyomitsu', u'', u'Miyachi'], [u'Nobuo', u'', u'Hirotsu'], [u'Takeshi', u'', u'Shigematsu'], [u'Seizaburo', u'', u'Kashiwagi']]",Clinical Infectious Diseases,2005,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/429241']
153,"Hayden FG, Gubareva LV, Monto AS, et al. Inhaled zanamivir for the prevention of influenza in families. N Engl J Med 2000; 343:1282-9.",10.1056/NEJM200011023431801,Inhaled Zanamivir for the Prevention of Influenza in Families,"[[u'Frederick', u'G.', u'Hayden'], [u'Larisa', u'V.', u'Gubareva'], [u'Arnold', u'S.', u'Monto'], [u'Thomas', u'C.', u'Klein'], [u'Michael', u'J.', u'Elliott'], [u'Janet', u'M.', u'Hammond'], [u'Stephen', u'J.', u'Sharp'], [u'Michael', u'J.', u'Ossi']]",New England Journal of Medicine,2000,[u'http://www.nejm.org/doi/abs/10.1056/NEJM200011023431801']
153,"Hayden FG, Belshe R, Villanueva C, et al. Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis. J Infect Dis 2004;189: 440-9.",10.1086/381128,"Management of Influenza in Households: A Prospective, Randomized Comparison of Oseltamivir Treatment With or Without Postexposure Prophylaxis","[[u'Robert', u'', u'Belshe'], [u'Catalina', u'', u'Villanueva'], [u'Riin', u'', u'Lanno'], [u'Claire', u'', u'Hughes'], [u'Ian', u'', u'Small'], [u'Regina', u'', u'Dutkowski'], [u'Penelope', u'', u'Ward'], [u'Jackie', u'', u'Carr']]",Journal of Infectious Diseases,2004,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/381128']
153,"Welliver R, Monto AS, Carewicz O, et al. Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial. JAMA 2001;285:748-",,Effectiveness of Oseltamivir in Preventing Influenza in Household Contacts,"[[u'A', u'Randomized Controlled', u'Trial'], [u'Robert', u'', u'Welliver'], [u'Arnold', u'S.', u'Monto'], [u'Otmar', u'', u'Carewicz'], [u'Edwig', u'', u'Schatteman'], [u'Michael', u'', u'Hassman'], [u'James', u'', u'Hedrick'], [u'Helen', u'C.', u'Jackson'], [u'Penelope', u'', u'Ward'], [u'John', u'S.', u'Oxford']]",,2001,[u'http://static.userland.com/gems/albanymed/flu.pdf']
153,"Hayden FG, Atmar RL, Schilling M, et al. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza. N Engl J Med 1999;341:1336-43.",10.1056/NEJM199910283411802,Use of the Selective Oral Neuraminidase Inhibitor Oseltamivir to Prevent Influenza,"[[u'Frederick', u'G.', u'Hayden'], [u'Robert', u'L.', u'Atmar'], [u'Margo', u'', u'Schilling'], [u'Casey', u'', u'Johnson'], [u'Donald', u'', u'Poretz'], [u'David', u'', u'Paar'], [u'Les', u'', u'Huson'], [u'Penelope', u'', u'Ward'], [u'Roger', u'G.', u'Mills']]",New England Journal of Medicine,1999,[u'http://www.nejm.org/doi/abs/10.1056/NEJM199910283411802']
153,"Oxford J, Balasingam S, Lambkin R. A new millennium conundrum: how to use a powerful class of influenza anti-neuraminidase drugs (NAIs) in the community. J Antimicrob Chemother 2004;53:133-6.",10.1093/jac/dkh037,A new millennium conundrum: how to use a powerful class of influenza anti-neuraminidase drugs (NAIs) in the community,"[[u'J.', u'', u'Oxford']]",Journal of Antimicrobial Chemotherapy,2004,[u'http://www.jac.oupjournals.org/cgi/doi/10.1093/jac/dkh037']
153,"Langley JM, Faughnan ME. Prevention of influenza in the general population. CMAJ 2004;171:1213-22.",,Prevention of influenza in the general population,"[[u'Joanne', u'M.', u'Langley'], [u'Marie', u'E.', u'Faughnan']]",,2004,[u'http://www.cmaj.ca/cgi/reprint/171/10/1213.pdf']
153,"Peters PH Jr, Gravenstein S, Norwood P, et al. Long-term use of oseltamivir for the prophylaxis of influenza in a vaccinated frail older population. J Am Geriatr Soc 2001;49: 1025-31.",10.1046/j.1532-5415.2001.49204.x,Long-Term Use of Oseltamivir for the Prophylaxis of Influenza in a Vaccinated Frail Older Population,"[[u'Patrick', u'H.', u'Peters'], [u'Stefan', u'', u'Gravenstein'], [u'Paul', u'', u'Norwood'], [u'Veerle', u'De', u'Bock'], [u'Anthony', u'Van', u'Couter'], [u'Michael', u'', u'Gibbens'], [u'Tony-Andrea', u'Von', u'Planta'], [u'Penelope', u'', u'Ward']]",Journal of The American Geriatrics Society,2001,[u'http://blackwell-synergy.com/doi/abs/10.1046/j.1532-5415.2001.49204.x']
153,"Monto AS, Rotthoff J, Teich E, et al. Detection and control of influenza outbreaks in well-vaccinated nursing home populations. Clin Infect Dis 2004;39:459-64.",10.1086/422646,Detection and Control of Influenza Outbreaks in Well‐Vaccinated Nursing Home Populations,"[[u'Arnold', u'S.', u'Monto'], [u'Judy', u'', u'Rotthoff'], [u'Esther', u'', u'Teich'], [u'M.', u'Louise', u'Herlocher'], [u'Rachel', u'', u'Truscon'], [u'Stephanie', u'', u'Elias'], [u'Suzanne', u'E.', u'Ohmit']]",Clinical Infectious Diseases,2004,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/422646']
153,"Hayden FG, Treanor JJ, Fritz RS, et al. Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment. JAMA 1999;282: 1240-6.",10.1001/jama.282.13.1240,Use of the Oral Neuraminidase Inhibitor Oseltamivir in Experimental Human Influenza: Randomized Controlled Trials for Prevention and Treatment,"[[u'F.', u'G.', u'Hayden']]",Jama-journal of The American Medical Association,1999,[u'http://jama.ama-assn.org/cgi/doi/10.1001/jama.282.13.1240']
153,"Freund B, Gravenstein S, Elliott M, Miller I. Zanamivir: a review of clinical safety. Drug Saf 1999;21:267-81.",10.2165/00002018-199921040-00003,Zanamivir: A Review of Clinical Safety,"[[u'Barbara', u'', u'Freund'], [u'Stefan', u'', u'Gravenstein'], [u'Michael', u'', u'Elliott'], [u'Irene', u'', u'Miller']]",Drug Safety,1999,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00002018-199921040-00003']
153,"Zambon M, Hayden FG. Position statement: global neuraminidase inhibitor susceptibility network. Antiviral Res 2001;49: 147-56.",10.1016/S0166-3542(01)00124-3,Position statement: global neuraminidase inhibitor susceptibility network,"[[u'Maria', u'', u'Zambon'], [u'Frederick', u'G.', u'Hayden']]",Antiviral Research,2001,"[u'http://www.sciencedirect.com/science/article/pii/S0166354201001243', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354201001243']"
153,"McKimm-Breschkin J, Trivedi T, Hampson A, et al. Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir. Antimicrob Agents Chemother 2003;47: 2264-72.",10.1128/AAC.47.7.2264-2272.2003,Neuraminidase Sequence Analysis and Susceptibilities of Influenza Virus Clinical Isolates to Zanamivir and Oseltamivir,"[[u'J.', u'', u'McKimm-Breschkin'], [u'T.', u'', u'Trivedi'], [u'A.', u'', u'Hampson'], [u'A.', u'', u'Hay'], [u'A.', u'', u'Klimov'], [u'M.', u'', u'Tashiro'], [u'F.', u'', u'Hayden'], [u'M.', u'', u'Zambon']]",Antimicrobial Agents and Chemotherapy,2003,"[u'http://aac.highwire.org/cgi/reprint/47/7/2264.pdf', u'http://aac.asm.org/cgi/reprint/47/7/2264.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.47.7.2264-2272.2003']"
153,"Kiso M, Mitamura K, Sakai-Tagawa Y, et al. Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet 2004;364:759-65.",10.1016/S0140-6736(04)16934-1,Resistant influenza A viruses in children treated with oseltamivir: descriptive study,"[[u'Maki', u'', u'Kiso'], [u'Keiko', u'', u'Mitamura'], [u'Yuko', u'', u'Sakai-Tagawa'], [u'Kyoko', u'', u'Shiraishi'], [u'Chiharu', u'', u'Kawakami'], [u'Kazuhiro', u'', u'Kimura'], [u'Frederick', u'G', u'Hayden'], [u'Norio', u'', u'Sugaya'], [u'Yoshihiro', u'', u'Kawaoka']]",Lancet,2004,"[u'http://www.sciencedirect.com/science/article/pii/S0140673604169341', u'http://download.thelancet.com/flatcontentassets/h1n1-flu/treatment/treatment-19.pdf', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673604169341']"
153,Moscona A. Oseltamivir-resistant influenza? Lancet 2004;364:733-4.,10.1016/S0140-6736(04)16947-X,Oseltamivir-resistant influenza?,"[[u'Anne', u'', u'Moscona']]",Lancet,2004,"[u'http://www.sciencedirect.com/science/article/pii/S014067360416947X', u'http://linkinghub.elsevier.com/retrieve/pii/S014067360416947X']"
153,"Herlocher ML, Truscon R, Elias S, et al. Influenza viruses resistant to the antiviral drug oseltamivir: transmission studies in ferrets. J Infect Dis 2004;190:1627-30.",10.1086/424572,Influenza Viruses Resistant to the Antiviral Drug Oseltamivir: Transmission Studies in Ferrets,"[[u'Rachel', u'', u'Truscon'], [u'Stephanie', u'', u'Elias']]",Journal of Infectious Diseases,2004,[u'http://www.journals.uchicago.edu/doi/abs/10.1086/424572']
153,"Monto AS, Gravenstein S, Elliott M, Colopy M, Schweinle J. Clinical signs and symptoms predicting influenza infection. Arch Intern Med 2000;160:3243-7.",,Clinical Signs and Symptoms Predicting Influenza Infection,"[[u'Arnold', u'S.', u'Monto'], [u'Stefan', u'', u'Gravenstein'], [u'Michael', u'', u'Elliott'], [u'Michael', u'', u'Colopy'], [u'Jo', u'', u'Schweinle']]",,2000,[u'http://archinte.ama-assn.org/cgi/reprint/160/21/3243.pdf']
153,"Cox NJ, Subbarao K. Influenza. Lancet 1999;354:1277-82.",10.1016/S0140-6736(99)01241-6,Influenza,"[[u'Nancy', u'J', u'Cox'], [u'Kanta', u'', u'Subbarao']]",Lancet,1999,"[u'http://www.sciencedirect.com/science/article/pii/S0140673699012416', u'http://linkinghub.elsevier.com/retrieve/pii/S0140673699012416']"
153,Storch GA. Rapid diagnostic tests for influenza. Curr Opin Pediatr 2003;15:77-84.,10.1007/s11908-005-0033-x,Rapid tests for influenza,"[[u'Constance', u'T.', u'Pachucki']]",Current Infectious Disease Reports,2005,"[u'http://www.springerlink.com/index/0383227661823303.pdf', u'http://www.springerlink.com/content/0383227661823303', u'http://www.springerlink.com/index/pdf/10.1007/s11908-005-0033-x', u'http://www.springerlink.com/index/10.1007/s11908-005-0033-x']"
153,"Ungchusak K, Auewarakul P, Dowell SF, et al. Probable person-to-person transmission of avian influenza A (H5N1). N Engl J Med 2005;352:333-40.",10.1056/NEJMoa044021,Probable Person-to-Person Transmission of Avian Influenza A (H5N1),"[[u'Kumnuan', u'', u'Ungchusak'], [u'Prasert', u'', u'Auewarakul'], [u'Scott', u'F.', u'Dowell'], [u'Rungrueng', u'', u'Kitphati'], [u'Wattana', u'', u'Auwanit'], [u'Pilaipan', u'', u'Puthavathana'], [u'Mongkol', u'', u'Uiprasertkul'], [u'Kobporn', u'', u'Boonnak'], [u'Chakrarat', u'', u'Pittayawonganon'], [u'Nancy', u'J.', u'Cox'], [u'Sherif', u'R.', u'Zaki'], [u'Pranee', u'', u'Thawatsupha'], [u'Malinee', u'', u'Chittaganpitch'], [u'Rotjana', u'', u'Khontong'], [u'James', u'M.', u'Simmerman'], [u'Supamit', u'', u'Chunsutthiwat']]",New England Journal of Medicine,2005,"[u'http://www.dld.go.th/birdflu/R&D/Research_AI/05%20Probably%20P2P%20Transmission%20of%20AI.pdf', u'http://www.cardinal.com/mps/brands/re/content/NEJM.pdf', u'http://www.birdflumanual.com/resources/Medical_References/files/ungchusak k etal probable persontoperson transmission of h5n1 nejm 2005 3524.pdf', u'http://www.nejm.org/doi/abs/10.1056/NEJMoa044021']"
153,"Li KS, Guan Y, Wang J, et al. Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia. Nature 2004;430:209-13.",10.1038/nature02746,Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia,"[[u'K.', u'S.', u'Li'], [u'Y.', u'', u'Guan'], [u'J.', u'', u'Wang'], [u'G.', u'J. D.', u'Smith'], [u'K.', u'M.', u'Xu'], [u'L.', u'', u'Duan'], [u'A.', u'P.', u'Rahardjo'], [u'P.', u'', u'Puthavathana'], [u'C.', u'', u'Buranathai'], [u'T.', u'D.', u'Nguyen'], [u'A.', u'T. S.', u'Estoepangestie'], [u'A.', u'', u'Chaisingh'], [u'P.', u'', u'Auewarakul'], [u'H.', u'T.', u'Long'], [u'N.', u'T. H.', u'Hanh'], [u'R.', u'J.', u'Webby'], [u'L.', u'L. M.', u'Poon'], [u'H.', u'', u'Chen'], [u'K.', u'F.', u'Shortridge'], [u'K.', u'Y.', u'Yuen'], [u'R.', u'G.', u'Webster'], [u'J.', u'S. M.', u'Peiris']]",Nature,2004,"[u'http://www.nature.com/doifinder/10.1038/nature02746', u'http://dx.doi.org/10.1038/nature02746', u'http://adsabs.harvard.edu/abs/2004Natur.430..209L']"
153,Stöhr K. Avian influenza and pandemics — research needs and opportunities. N Engl J Med 2005;352:405-7.,10.1056/NEJMe048344,Avian Influenza and Pandemics — Research Needs and Opportunities,"[[u'Klaus', u'', u'St\xf6hr']]",New England Journal of Medicine,2005,"[u'http://cmbi.bjmu.edu.cn/news/report/2005/flu/13.pdf', u'http://www.flu.org.cn/upfile/attachment/2005127134721.pdf', u'http://cmbi.bjmu.edu.cn/news/report/2005/flu/14.pdf', u'http://www.biotech.org.cn/news/news/file/20050128144343.pdf', u'http://www.nejm.org/doi/abs/10.1056/NEJMe048344']"
153,"Monto AS. The threat of an avian influenza pandemic. N Engl J Med 2005;352: 323-5. [Erratum, N Engl J Med 2005;352:",10.1056/NEJMp048343,The Threat of an Avian Influenza Pandemic,"[[u'Arnold', u'S.', u'Monto']]",New England Journal of Medicine,2005,"[u'http://www.nejm.org/doi/abs/10.1056/NEJMp048343', u'http://linksmedia.org/shared/USAIDavian/Panama Materiales del Taller 11-13 julio/MATERIAL de REFERENCIA/The threat of AI pandemic.pdf', u'http://www.flu.org.cn/upfile/attachment/2005127134706.pdf', u'http://cmbi.bjmu.edu.cn/news/report/2005/flu/88.pdf']"
153,"Trampuz A, Prabhu RM, Smith TF, Baddour LM. Avian influenza: a new pandemic threat? Mayo Clin Proc 2004;79:523-30. [Erratum, Mayo Clin Proc 2004;79:833.]",10.4065/79.4.523,Avian Influenza: A New Pandemic Threat?,"[[u'A.', u'', u'Trampuz'], [u'R.', u'M.', u'Prabhu'], [u'T.', u'F.', u'Smith'], [u'L.', u'M.', u'Baddour']]",Mayo Clinic Proceedings,2004,[u'http://www.mayoclinicproceedings.com/cgi/doi/10.4065/79.4.523']
153,"Tumpey TM, Garcia-Sastre A, Mikulasova A, et al. Existing antivirals are effective against influenza viruses with genes from the 1918 pandemic virus. Proc Natl Acad Sci U S A 2002;99:13849-54.",10.1073/pnas.212519699,Existing antivirals are effective against influenza viruses with genes from the 1918 pandemic virus,"[[u'Terrence', u'M.', u'Tumpey'], [u'Adolfo', u'', u'Garc\xeda-Sastre'], [u'Andrea', u'', u'Mikulasova'], [u'Jeffery', u'K.', u'Taubenberger'], [u'David', u'E.', u'Swayne'], [u'Peter', u'', u'Palese'], [u'Christopher', u'F.', u'Basler']]",Proceedings of The National Academy of Sciences,2002,"[u'http://birdflubook.com/resources/Tumpey13849.pdf', u'http://www.pnas.org/cgi/doi/10.1073/pnas.212519699', u'http://adsabs.harvard.edu/abs/2002PNAS...9913849T']"
153,"Leneva IA, Goloubeva O, Fenton RJ, Tisdale M, Webster RG. Efficacy of zanamivir against avian influenza A viruses that possess genes encoding H5N1 internal proteins and are pathogenic in mammals. Antimicrob Agents Chemother 2001;45: 1216-24.",10.1128/AAC.45.4.1216-1224.2001,Efficacy of Zanamivir against Avian Influenza A Viruses That Possess Genes Encoding H5N1 Internal Proteins and Are Pathogenic in Mammals,"[[u'IRINA', u'A.', u'LENEVA'], [u'OLGA', u'', u'GOLOUBEVA'], [u'ROBERT', u'J.', u'FENTON'], [u'MARGARET', u'', u'TISDALE'], [u'ROBERT', u'G.', u'WEBSTER']]",Antimicrobial Agents and Chemotherapy,2001,"[u'http://aac.asm.org/cgi/reprint/45/4/1216.pdf', u'http://aac.asm.org/cgi/doi/10.1128/AAC.45.4.1216-1224.2001']"
153,"Leneva IA, Roberts N, Govorkova EA, Goloubeva OG, Webster RG. The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/ 1074/99 (H9N2) influenza viruses. Antiviral Res 2000;48:101-15.",10.1016/S0166-3542(00)00123-6,The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses,"[[u'Irina', u'A.', u'Leneva'], [u'Noel', u'', u'Roberts'], [u'Elena', u'A.', u'Govorkova'], [u'Olga', u'G.', u'Goloubeva'], [u'Robert', u'G.', u'Webster']]",Antiviral Research,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0166354200001236', u'http://linkinghub.elsevier.com/retrieve/pii/S0166354200001236']"
153,"Mills CE, Robins JM, Lipsitch M. Transmissibility of 1918 pandemic influenza. Nature 2004;432:904-6.",10.1038/nature03063,Transmissibility of 1918 pandemic influenza,"[[u'James', u'M.', u'Robins'], [u'Marc', u'', u'Lipsitch'], [u'Christina', u'E.', u'Mills']]",Nature,2005,"[u'http://www.nature.com/doifinder/10.1038/nature03063', u'http://dx.doi.org/10.1038/nature03063']"
153,"Balicer RD, Huerta M, Grotto I. Tackling the next influenza pandemic. BMJ 2004;328: 1391-2.",10.1136/bmj.328.7453.1391,Tackling the next influenza pandemic,"[[u'Ran', u'D', u'Balicer'], [u'Michael', u'', u'Huerta'], [u'Itamar', u'', u'Grotto']]",British Medical Journal,2004,"[u'http://www.bmj.com/cgi/doi/10.1136/bmj.328.7453.1391', u'http://dx.doi.org/10.1136/bmj.328.7453.1391']"
95,Stiver G. The treatment of influenza with antiviral drugs. Can Med Assoc J 2003;168(1):49–57.,,The treatment of influenza with antiviral drugs,"[[u'Grant', u'', u'Stiver']]",,0,"[u'http://www.ualberta.ca/~mlalu/ref03.pdf', u'http://www.ualberta.ca/~mlalu/CMAJantiviral.pdf', u'http://www.cmaj.ca/cgi/reprint/168/1/49.pdf']"
95,"Stott DJ, Kerr G, Carman WF. Nosocomial transmission of influenza. Occup Med 2002;52(5):249–53.",10.1093/occmed/52.5.249,Nosocomial transmission of influenza,"[[u'D.', u'J.', u'Stott']]",Occupational Medicine-oxford,2002,[u'http://occmed.oupjournals.org/cgi/doi/10.1093/occmed/52.5.249']
95,"Dolin R, Reichman RC, Madore HP, Maynard R, Linton PN, Webber-Jones J . A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection. N Engl J Med 1982;307(10):580–4.",10.1056/NEJM198209023071002,A Controlled Trial of Amantadine and Rimantadine in the Prophylaxis of Influenza a Infection,"[[u'Raphael', u'', u'Dolin'], [u'Richard', u'C.', u'Reichman'], [u'H.', u'Paul', u'Madore'], [u'Raina', u'', u'Maynard'], [u'Pamela', u'N.', u'Linton'], [u'Joan', u'', u'Webber-Jones']]",New England Journal of Medicine,1982,[u'http://www.nejm.org/doi/abs/10.1056/NEJM198209023071002']
95,Hayden FG. Pandemic influenza: is an antiviral response realistic? Pediatr Infect Dis J 2004;23:S262–9.,10.1097/01.inf.0000144680.39895.ce,Pandemic Influenza: Is an Antiviral Response Realistic?,"[[u'Frederick', u'G.', u'Hayden']]",Pediatric Infectious Disease Journal,2004,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00006454-200411001-00012']
95,"Thompson J, Fleet W, Lawrence E, et al. A comparison of acetaminophen and rimantadine in the treatment of influenza A infection in children. J Med Virol 1987;21(3):249–55.",10.1002/jmv.1890210308,A comparison of acetaminophen and rimantadine in the treatment of influenza A infection in children,"[[u'Juliette', u'', u'Thompson'], [u'William', u'', u'Fleet'], [u'Eileen', u'', u'Lawrence'], [u'Elizabeth', u'', u'Pierce'], [u'Laurie', u'', u'Morris'], [u'Peter', u'', u'Wright']]",Journal of Medical Virology,1987,[u'http://doi.wiley.com/10.1002/jmv.1890210308']
95,"Crawford SA, Clover RD, Abell TD, et al. Rimantadine prophylaxis in children: a follow-up study. Pediatr Infect Dis J 1988;7(6):379–83.",10.1097/00006454-198806000-00002,Rimantadine prophylaxis in children: a follow-up study,"[[u'STEVEN', u'A.', u'CRAWFORD'], [u'RICHARD', u'D.', u'CLOVER'], [u'TROY', u'D.', u'ABELL'], [u'CHRISTIAN', u'N.', u'RAMSEY'], [u'W.', u'PAUL', u'GLEZEN'], [u'ROBERT', u'B.', u'COUCH']]",Pediatric Infectious Disease Journal,1988,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00006454-198806000-00002']
95,"Nahata MC, Brady MT. Serum concentrations and safety of rimantadine in paediatric patients. Eur J Clin Pharmacol 1986;30(6):719–22.",10.1007/BF00608222,Serum concentrations and safety of rimantadine in paediatric patients,"[[u'M.', u'C.', u'Nahata'], [u'M.', u'T.', u'Brady']]",European Journal of Clinical Pharmacology,1986,"[u'http://www.springerlink.com/index/q9787t1687154331.pdf', u'http://www.springerlink.com/content/q9787t1687154331', u'http://www.springerlink.com/index/10.1007/BF00608222', u'http://www.springerlink.com/index/pdf/10.1007/BF00608222']"
95,"Hayden FG, Osterhaus ADME, Treanor JJ, et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza virus infections. N Engl J Med 1997;337(13):874–80.",10.1056/NEJM199709253371302,Efficacy and Safety of the Neuraminidase Inhibitor Zanamivir in the Treatment of Influenzavirus Infections,"[[u'Frederick', u'G.', u'Hayden'], [u'Albert', u'D. M. E.', u'Osterhaus'], [u'John', u'J.', u'Treanor'], [u'Douglas', u'M.', u'Fleming'], [u'Fred', u'Y.', u'Aoki'], [u'Karl', u'G.', u'Nicholson'], [u'Arthur', u'M.', u'Bohnen'], [u'Hilary', u'M.', u'Hirst'], [u'Oliver', u'', u'Keene'], [u'Kevin', u'', u'Wightman']]",New England Journal of Medicine,1997,[u'http://www.nejm.org/doi/abs/10.1056/NEJM199709253371302']
95,"Hedrick JA, Barzilai A, Behre U, et al. Zanamivir for the treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trial. Pediatr Infect Dis J 2000;19:410–17.",10.1097/00006454-200005000-00005,Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trial,"[[u'JAMES', u'A.', u'HEDRICK'], [u'ASHER', u'', u'BARZILAI'], [u'ULRICH', u'', u'BEHRE'], [u'FREDERICK', u'W.', u'HENDERSON'], [u'JANET', u'', u'HAMMOND'], [u'LUCY', u'', u'REILLY'], [u'OLIVER', u'', u'KEENE']]",Pediatric Infectious Disease Journal,2000,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00006454-200005000-00005']
95,"Imuta F, Toyoda M, Toyoda T. New application method of zanamivir with a straw. Pediatr Int 2003;45:366–7. 102 TREATMENT OF INFLUENZA IN PEDIATRIC PATIENTS  Townsend and Eiland",10.1046/j.1442-200X.2003.01724.x,New application method of zanamivir with a straw,"[[u'Fusae', u'', u'Imuta'], [u'Michiko', u'', u'Toyoda'], [u'Tetsuya', u'', u'Toyoda']]",Pediatrics International,2003,[u'http://www.blackwell-synergy.com/links/doi/10.1046%2Fj.1442-200X.2003.01724.x']
95,"Makela MJ, Pauksens K, Rostila T, et al. Clinical efficacy and safety of the orally inhaled neuraminidase inhibitors zanamivir in the treatment of influenza: a randomized, double-blind, placebo-controlled European study. J Infect 2000;40:42–8.",10.1053/jinf.1999.0602,"Clinical Efficacy and Safety of the Orally Inhaled Neuraminidase Inhibitor Zanamivir in the Treatment of Influenza: a Randomized, Double-blind, Placebo-controlled European Study","[[u'M.', u'J.', u'M\xe4kel\xe4'], [u'K.', u'', u'Pauksens'], [u'T.', u'', u'Rostila'], [u'D.', u'M.', u'Fleming'], [u'C.', u'Y.', u'Man'], [u'O.', u'N.', u'Keene'], [u'A.', u'', u'Webster']]",Journal of Infection,2000,"[u'http://www.sciencedirect.com/science/article/pii/S0163445399906023', u'http://linkinghub.elsevier.com/retrieve/pii/S0163445399906023', u'http://download.thelancet.com/flatcontentassets/h1n1-flu/treatment/treatment-15.pdf']"
95,"Oo C, Barrett J, Hill G, et al. Pharmacokinetics and dosage recommendations for an oseltamivir oral suspension for the treatment of influenza in children. Paediatr Drugs 2001; 3(3):229–36.",10.2165/00128072-200103030-00005,Pharmacokinetics and Dosage Recommendations for an Oseltamivir Oral Suspension for the Treatment of Influenza in Children,"[[u'Charles', u'', u'Oo'], [u'Joanne', u'', u'Barrett'], [u'George', u'', u'Hill'], [u'Jason', u'', u'Mann'], [u'Albert', u'', u'Dorr'], [u'Regina', u'', u'Dutkowski'], [u'Penny', u'', u'Ward']]",Pediatric Drugs,2001,[u'http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00128072-200103030-00005']
95,"Oo C, Hill G, Dorr A, Lui B, Boellner S, Ward P. Pharmacokinetics of anti-influenza prodrug oseltamivir in children aged 1–5 years. Eur J Clin Pharmacol 2003;59:411–15. ",10.1007/s00228-003-0639-6,Pharmacokinetics of anti-influenza prodrug oseltamivir in children aged 1–5 years,"[[u'Charles', u'', u'Oo'], [u'George', u'', u'Hill'], [u'Albert', u'', u'Dorr'], [u'Baolian', u'', u'Liu'], [u'Samuel', u'', u'Boellner'], [u'Penelope', u'', u'Ward']]",European Journal of Clinical Pharmacology,2003,"[u'http://www.springerlink.com/content/u2u6ufaxht4qgjgl', u'http://www.springerlink.com/index/u2u6ufaxht4qgjgl.pdf', u'http://www.springerlink.com/openurl.asp?genre=article&id=doi:10.1007/s00228-003-0639-6', u'http://www.springerlink.com/index/pdf/10.1007/s00228-003-0639-6']"
